Roche Holding AG

ROG

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

3 cheap Wide Moat stocks in a divided industry

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far. 
stocks

Obesity drug stocks: Where to invest now

Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.
stocks

10 global stocks for a recession

These undervalued stocks come from high-quality companies in defensive sectors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,789.7043.800.50%
CAC 407,950.178.530.11%
DAX 4021,732.054.850.02%
Dow JONES (US)44,885.092.960.01%
FTSE 1008,673.9627.080.31%
HKSE20,225.1127.340.14%
NASDAQ19,930.36248.611.26%
Nikkei 22539,572.4958.520.15%
NZX 50 Index12,995.0166.630.52%
S&P 5006,111.7040.530.67%
S&P/ASX 2008,532.3038.600.45%
SSE Composite Index3,250.602.03-0.06%

Market Movers